Events
ASCO 2025: Trastuzumab deruxtecan can help some people with advanced gastric cancers live about 3 months longer
- ASCO 2025: Exercise programme may lower risk of recurrence and death for some colon cancer survivors
- ASCO 2025: Perioperative treatment with durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers
- ASCO 2025: Zanidatamab plus chemotherapy shows strong first-line efficacy in HER2-positive gastro-oesophageal adenocarcinoma
The OJC Episode 38: ASCO 2021 GU Roundtable
The Oncology Journal Club Podcast Episode 38 In today’s special ASCO 2021 episode Craig Underhill talks to Lisa Horvath and…
Have you heard soy is linked to cancer risk or can ‘feminise’ men? Here’s what the science really says
Karen Murphy, University of South Australia Soy is common in many Asian cuisines, and is growing more popular in Western…









